Q0139 HCPCS Level II code: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)
Q0139 is the HCPCS code for “Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
Q0139Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)
Short description: Ferumoxytol, esrd use
HCPCS · United States
Medicare details
The indicators CMS publishes with Q0139 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2010
Where Q0139 sits
- 1Q codesTemporary codes
- 2Active code Q0139Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code Q0139 mean?
Q0139 is the HCPCS code for “Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover Q0139?
CMS lists Q0139’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside Q0139
All Q codesQ0111Wet mounts, including preparations of vaginal, cervical or skin specimensQ0112All potassium hydroxide (koh) preparationsQ0113Pinworm examinationsQ0114Fern testQ0115Post-coital direct, qualitative examinations of vaginal or cervical mucousQ0138Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)Q0144Azithromycin dihydrate, oral, capsules/powder, 1 gramQ0155Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy…Q0161Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy…Q0162Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to…Q0163Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy…Q0164Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy…